83 results
Page 3 of 5
8-K
EX-99.1
ffw5ecs7
13 May 21
Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates
7:34am
8-K
EX-99.1
475cmr602dhw l9
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
424B5
zkhj7iq
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
0eq2r6f7z9mjrxh2xw2
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
iludjgz7juk5i0 gy4q
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
finqim7h1
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
EX-99.1
1blt 1y90l
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
q5caulfcuyd4ul0eiia7
14 Aug 20
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
6:07am
8-K
EX-99.1
1ux4gt2n7 3fz5er8k
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.2
3meir nxnms56owb
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
ysd0cz8xp9bcy5uc
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-99.1
rkvavwsr1d
14 May 20
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
8:12am